Analysis

Health And Life Sciences Policy To Watch In 2020

Law360 (January 1, 2020, 12:04 PM EST) -- An extraordinary feud among the Trump administration's top health care officials will serve as a riveting backdrop in 2020 to contentious debates over hospital reimbursement and drug prices. Here, Law360 gets you up to speed on the biggest health care and life sciences policies to watch this year.

Battle of Health Agency Bosses Looms Large

The tail end of 2019 generated a remarkable series of news articles about an increasingly acrimonious working relationship between Alex Azar, secretary of the U.S. Department of Health and Human Services, and Seema Verma, administrator of the Centers for Medicare & Medicaid Services within HHS....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!